Status | Study |
Active, not recruiting |
Study Name: A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis Condition: Diffuse Cutaneous Systemic Sclerosis Date: 2014-06-03 Interventions: Drug: Abatacept Subjects will |
Recruiting |
Study Name: Autologous Stem Cell Transplantation for Progressive Systemic Sclerosis Condition: Scleroderma Cardiac Involvement Autologous Stem Cell Trans Date: 2013-07-01 Interventions: Drug: Autologous stemcell transplantation with CD (cluster of differentiation) 34 selected stem cells If |
Completed |
Study Name: A Non-Interventional Pilot Study Assessing Whether Lysyl Oxidase-like 2 (LOXL2) is Present in Subjects With Scleroderma Condition: Limited Scleroderma Diffuse Scleroderma Date: 2013-06-05 |
Active, not recruiting |
Study Name: IVIG Treatment in Systemic Sclerosis Condition: Systemic Sclerosis Diffuse Scleroderma Date: 2013-01-28 Interventions: Biological: Privigen Subjects will receive 2 g/kg/mo of Privigen® for 6 months if randomized to the |
Completed |
Study Name: Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis Condition: Systemic Sclerosis Date: 2012-08-15 Interventions: Drug: Belimumab Belimumab (Benlysta®) decreases B-Cell survival and has been FDA approved for the t |
Recruiting |
Study Name: Serial Night Time Position Splint on Systemic Sclerosis Condition: Diffuse Systemic Sclerosis Date: 2012-04-25 Interventions: Device: Serial night time position splint |
Terminated |
Study Name: Proof of Concept Trial of Gleevec (Imatinib) in Active Diffuse Scleroderma Condition: Scleroderma Date: 2012-03-01 Interventions: Drug: Imatinib mesylate 200 mg |
Completed |
Study Name: Fresolimumab In Systemic Sclerosis Condition: Diffuse Systemic Sclerosis Date: 2011-01-25 Interventions: Drug: Fresolimumab intravenous fresolimumab 1mg/kg, first 8 patients; 5 mg/kg following 8 patients |
Completed |
Study Name: Study of Ambrisentan With Antifibrotic Agent Combination Therapy in Diffuse Systemic Sclerosis Condition: Systemic Sclerosis Scleroderma Date: 2010-03-24 Interventions: Drug: Ambrisentan Drug is dispensed in tablet form. Ambris |
Completed |
Study Name: AIMSPRO in Established Diffuse Cutaneous Systemic Sclerosis Condition: Systemic Sclerosis Date: 2008-10-07 Interventions: Drug: Hyperimmune caprine serum |